(3S,4S,5R,6R)-4-[(2S,3S,4R,5S,6R)-5-[(2S,3S,4S,5R,6R)-3,5-Dihydroxy-6-(hydroxymethyl)-4-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol

Term ID

CHEBI:155562

Synonyms

beta-D-manno-hexopyranosyl-(1->3)-beta-D-manno-hexopyranosyl-(1->4)-beta-D-manno-hexopyranosyl-(1->3)-D-manno-hexopyranose
Man(b1-3)Man(b1-4)Man(b1-3)Man
WURCS=2.0/2,4,3/[a1122h-1x_1-5][a1122h-1b_1-5]/1-2-2-2/a3-b1_b4-c1_c3-d1

Definition

References

GlyGen:G98865DJ
GlyTouCan:G98865DJ

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from (3S,4S,5R,6R)-4-[(2S,3S,4R,5S,6R)-5-[(2S,3S,4S,5R,6R)-3,5-Dihydroxy-6-(hydroxymethyl)-4-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol

Phenotype where environments contain (3S,4S,5R,6R)-4-[(2S,3S,4R,5S,6R)-5-[(2S,3S,4S,5R,6R)-3,5-Dihydroxy-6-(hydroxymethyl)-4-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol

Phenotype modified by environments containing (3S,4S,5R,6R)-4-[(2S,3S,4R,5S,6R)-5-[(2S,3S,4S,5R,6R)-3,5-Dihydroxy-6-(hydroxymethyl)-4-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol

Phenotype affecting (3S,4S,5R,6R)-4-[(2S,3S,4R,5S,6R)-5-[(2S,3S,4S,5R,6R)-3,5-Dihydroxy-6-(hydroxymethyl)-4-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol

Human Disease Model